Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|29|4564-4569

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.29, 2012-10, pp. : 4564-4569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intrathecal triamcinolone is more beneficial than IV mitoxantrone for the treatment of chronic progressive multiple sclerosis (MS)

By  

Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Management of Secondary-Progressive Multiple Sclerosis

By Gavin Giovannoni  

CNS Drugs, Vol. 18, Iss. 10, 2004-01 ,pp. : 653-669

Adis International

Access to resources Recommend Favorite

Comparison of the Efficacy of Intralesional Triamcinolone Acetonide and 5-Fluorouracil Tattooing for the Treatment of Keloids

By Sadeghinia Ali   Sadeghinia Saeed  

Dermatologic Surgery, Vol. 38, Iss. 1, 2012-01 ,pp. : 104-109

Elsevier

Access to resources Recommend Favorite

Dose and Frequency of Administration of Interferon- Affect its Efficacy in Multiple Sclerosis

By Sharief M.K.  

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 551-559

Adis International

Access to resources Recommend Favorite

Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-02 ,pp. : 149-172

Bentham Science Publishers

Access to resources Recommend Favorite